
Opinion|Videos|July 23, 2024
NCCN Recommendations by PD-L1 Expression Level
A panel of experts discuss how the NCCN guideline recommendations differ for patients with and without PD-L1 expression.
Advertisement
Episodes in this series

Video content above is prompted by the following:
- How do the NCCN guideline recommendations differ for patients without PD-L1 expression (<1%) compared with those with low (1%-49%) or high (≥50%) expression?
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
Hans Lee, MD, Discusses “Off-the-Shelf” Solution for Rare Blood Disorder With No Approved Therapies
2
AI Billing, GLP-1s Among Forces Driving 9% Health Cost Spike
3
ACP Names Semaglutide, Tirzepatide as First-Line Pharmacotherapy for Obesity
4
CMS Proposes Permanent Rules for Medicare Drug Price Negotiation
5


